Targeting endothelial permeability in the EPR effect

B Lahooti, RG Akwii, FT Zahra, MS Sajib… - Journal of Controlled …, 2023 - Elsevier
The characteristics of the primary tumor blood vessels and the tumor microenvironment drive
the enhanced permeability and retention (EPR) effect, which confers an advantage towards …

Multicellular effects of STAT3 in non-small cell lung cancer: Mechanistic insights and therapeutic opportunities

S Parakh, M Ernst, AR Poh - Cancers, 2021 - mdpi.com
Simple Summary Persistent activation of STAT3 is frequently observed in non-small cell lung
cancer and is associated with a poor prognosis. Given the multifaceted role of STAT3 …

IGF1R acts as a cancer-promoting factor in the tumor microenvironment facilitating lung metastasis implantation and progression

E Alfaro-Arnedo, IP López, S Piñeiro-Hermida… - Oncogene, 2022 - nature.com
Given the long-term ineffectiveness of current therapies and late-stage diagnoses, lung
cancer is a leading cause of malignant diseases. Tumor progression is influenced by cancer …

Telomerase deficiency and dysfunctional telomeres in the lung tumor microenvironment impair tumor progression in NSCLC mouse models and patient-derived …

S Piñeiro-Hermida, G Bosso… - Cell Death & …, 2023 - nature.com
Non-small cell lung cancer (NSCLC) is a leading cause of cancer death. Tumor progression
depends on interactions of cancer cells with the tumor microenvironment. Here, we find …

Autophagy: a key player in pancreatic cancer progression and a potential drug target

J Gillson, YS Abd El-Aziz, LYW Leck, PJ Jansson… - Cancers, 2022 - mdpi.com
Simple Summary With the mortality rate of pancreatic cancer predicted to rise over the
coming years, it is essential that effective treatment strategies are developed as soon as …

The tumor microenvironment in classic Hodgkin's lymphoma in responder and no-responder patients to first line ABVD therapy

R Tamma, G Ingravallo, F Gaudio, A d'Amati… - Cancers, 2023 - mdpi.com
Simple Summary The extracellular matrix surrounding or infiltrating tumor tissues, tumor
cells, endothelial cells, immune cells, fibroblasts, macrophages, as well as soluble …

HDGF enhances VEGF‑dependent angiogenesis and FGF‑2 is a VEGF‑independent angiogenic factor in non‑small cell lung cancer

R Eguchi, I Wakabayashi - Oncology reports, 2020 - spandidos-publications.com
Non‑small cell lung cancer (NSCLC) accounts for over 80% of all diagnosed lung cancer
cases. Lung cancer is the leading cause of cancer‑related deaths worldwide. Most NSCLC …

Biomedical applications of non-small cell lung cancer spheroids

JM Rozenberg, GI Filkov, AV Trofimenko… - Frontiers in …, 2021 - frontiersin.org
Lung malignancies accounted for 11% of cancers worldwide in 2020 and remained the
leading cause of cancer deaths. About 80% of lung cancers belong to non-small cell lung …

Gold nanoparticles as antiangiogenic and antimetastatic agents

A Zamborlin, V Voliani - Drug Discovery Today, 2023 - Elsevier
Highlights•Invasion and metastases are central features of cancer malignancy and constitute
the primary cause of death for> 90% of patients with cancer.•The establishment of effective …

Update overview of the role of angiopoietins in lung cancer

D Tsakogiannis, A Nikolakopoulou, F Zagouri… - Medicina, 2021 - mdpi.com
Angiogenesis is a biological process that involves the formation of new blood vessels from
the existing vasculature, and it plays a fundamental role in the development and progression …